| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
20,766,000 | 17,682,000 | 15,641,000 | 17,519,000 | 20,028,000 |
|
Cost of Revenue
|
-8,256,000 | -7,599,000 | -6,547,000 | -6,500,000 | -6,257,000 |
|
Gross Profit
|
12,510,000 | 10,083,000 | 9,094,000 | 11,019,000 | 13,771,000 |
|
Selling, General and Administrative Expenses
|
-1,876,000 | -1,860,000 | -1,794,000 | -1,825,000 | -1,704,000 |
|
Research and Development Expenses
|
-2,096,000 | -2,083,000 | -1,959,000 | -1,863,000 | -1,670,000 |
|
Operating Income/Expenses
|
-3,972,000 | -3,943,000 | -3,753,000 | -3,688,000 | -3,374,000 |
|
Total Operating Profit/Loss
|
8,538,000 | 6,140,000 | 5,341,000 | 7,331,000 | 10,397,000 |
| Total Net Finance Income/Expense
|
-564,000 | -543,000 | -508,000 | -353,000 | -214,000 |
| Irregular Income/Expenses
|
-73,000 | -117,000 | 124,000 | 0 | -257,000 |
|
Other Income/Expense, Non-Operating
|
228,000 | 230,000 | 496,000 | 440,000 | 106,000 |
|
Non-Operating Income/Expenses, Total
|
-409,000 | -430,000 | 112,000 | 87,000 | -365,000 |
|
Pretax Income
|
8,129,000 | 5,710,000 | 5,453,000 | 7,418,000 | 10,032,000 |
|
Provision for Income Tax
|
-1,016,000 | -709,000 | -654,000 | -908,000 | -1,283,000 |
|
Net Income from Continuing Operations
|
7,113,000 | 5,001,000 | 4,799,000 | 6,510,000 | 8,749,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
7,113,000 | 5,001,000 | 4,799,000 | 6,510,000 | 8,749,000 |
|
Net Income after Non-Controlling/Minority Interests
|
7,113,000 | 5,001,000 | 4,799,000 | 6,510,000 | 8,749,000 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-41,000 | -28,000 | -24,000 | -34,000 | -40,000 |
|
Net Income Available to Common Stockholders
|
7,072,000 | 4,973,000 | 4,775,000 | 6,476,000 | 8,709,000 |
|
Dilution to Earnings
|
-- | -- | -- | 1,000 | 1,000 |
|
Diluted Net Income Available to Common Stockholders
|
7,072,000 | 4,973,000 | 4,775,000 | 6,477,000 | 8,710,000 |
|
Common Dividend per Share
|
2.94 | 5.50 | 5.26 | 5.02 | 4.69 |
| Basic EPS
|
7.76 | 5.47 | 5.24 | 7.13 | 9.51 |
| Diluted EPS
|
7.71 | 5.45 | 5.20 | 7.07 | 9.41 |
|
Basic Weighted Average Shares Outstanding
|
911,250 | 909,000 | 912,000 | 908,000 | 916,000 |
|
Diluted Weighted Average Shares Outstanding
|
916,000 | 913,000 | 919,000 | 916,000 | 926,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
8,693,000 | 6,253,000 | 5,961,000 | 7,771,000 | 10,246,000 |
|
EBITDA
|
10,956,000 | 8,252,000 | 7,541,000 | 9,009,000 | 11,225,000 |
|
Normalized EBITDA
|
11,430,000 | 8,790,000 | 7,804,000 | 9,371,000 | 11,768,000 |
|
Normalized Income
|
7,531,756.63 | 5,476,256 | 5,030,440 | 6,827,836 | 9,222,496 |
12/31/2022 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade